Skip to content
All tests

Your test, explained

5 min read

Thyroid Antibodies Panel Blood Test: The Complete Autoimmune Evaluation

A highly precise, comprehensive quantitative panel measuring both Thyroid Peroxidase (TPO) and Thyroglobulin (Tg) autoantibodies. It is the gold-standard diagnostic tool for identifying Hashimoto's thyroiditis, evaluating goiters, and assessing obstetric autoimmune risks.

At a glance

Start with the details.

A price isn’t listed yet. Explore the guide below.

Sample
Blood (Serum)
Typical turnaround
2 - 3 days
Before your appointment

Your options, side by side

Compare retailer prices.

Find a listing that fits your needs. Review the details, then order with the retailer.

0 listings

No retailer listings yet.

Read the test guide or explore other tests in the directory.

Explore tests

Prices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.

Understand before you decide

The test, explained.

Overview

In advanced clinical endocrinology, evaluating a failing thyroid solely through TSH is an outdated, reactionary approach. Over 80% of hypothyroidism in the developed world is driven by an autoimmune assault. If you do not test the immune system, you are missing the root cause of the disease.

As a senior clinical immunologist and endocrinologist, I utilize the comprehensive Thyroid Antibodies Panel as the absolute baseline for diagnosing thyroid dysfunction. Your immune system can attack your thyroid on two distinct fronts: it can attack the enzyme that makes the hormone (Thyroid Peroxidase - TPO), or it can attack the protein scaffold where the hormone is stored (Thyroglobulin - Tg). While many basic clinics only test for TPO antibodies, clinical data shows that up to 15% of patients with Hashimoto's Thyroiditis are exclusively positive for Thyroglobulin antibodies. By running this dual panel, we completely eliminate the diagnostic blind spot, allowing us to accurately predict impending thyroid failure months or even years before your standard metabolic labs flag an issue.

About this test

Advanced Clinical Diagnostic Utility of the Thyroid Antibodies Panel

To extract genuine diagnostic power from this panel, one must understand the distinct pathology represented by each antibody and how they collectively predict glandular destruction.

1. The Dual Assault: TPO vs. Thyroglobulin
  • Comprehensive Coverage: Thyroid Peroxidase (TPO) is the enzyme that attaches iodine to tyrosine to create thyroid hormone. Thyroglobulin (Tg) is the large precursor protein that acts as the storage matrix for these hormones. While TPO antibodies are the primary driver of the cytotoxic destruction seen in Hashimoto's, Tg antibodies often appear first during the initial breakdown of the thyroid follicles. Testing both ensures we do not miss the 10-15% of autoimmune patients who are seronegative for TPO but highly positive for TgAb.

2. The Predictive Autoimmune Horizon
  • Proactive vs. Reactive: Autoantibodies are the 'smoke' before the 'fire' of organ failure. Patients frequently present with Subclinical Hypothyroidism (normal Free T4, slightly elevated TSH) or even perfectly euthyroid labs, yet complain of profound fatigue and weight gain. High titers of these antibodies confirm that an active, smoldering immune attack is occurring. Clinical data demonstrates that patients positive for both antibodies progress to overt, irreversible clinical hypothyroidism at a significantly accelerated rate.

3. Reproductive Endocrinology and Fertility
  • The Obstetric Mandate: This panel is mandatory in advanced reproductive medicine. Women with normal thyroid function but highly elevated TPO or Tg antibodies face a 2 to 3-fold increased independent risk of recurrent first-trimester miscarriage, premature rupture of membranes, and Postpartum Thyroiditis. These antibodies cross the placental barrier and act as a biomarker for a systemic, pro-inflammatory maternal immune state.

When to discuss this test

You should prioritize this comprehensive immunological evaluation when:

  • You are experiencing classic hypothyroid symptoms (unyielding exhaustion, weight gain, brain fog, severe cold intolerance, hair loss), particularly if your physician previously dismissed you due to a 'normal' TSH.
  • You present with a visibly enlarged thyroid gland (goiter) or frequently feel a sensation of tightness or a 'lump' in your throat (globus sensation).
  • You are struggling with unexplained infertility, recurrent miscarriages, or are currently planning a pregnancy and have a family history of autoimmune disease.
  • You have already been diagnosed with another autoimmune disorder (e.g., Celiac Disease, Rheumatoid Arthritis, Type 1 Diabetes), as autoimmune conditions aggressively cluster together (Polyautoimmunity).

Who may benefit

This panel is an absolute necessity for endocrinologists diagnosing the exact etiology of thyroid failure, obstetricians mitigating autoimmune-driven miscarriage risks, and functional medicine practitioners utilizing dietary and immunomodulatory protocols to cool systemic inflammation before the thyroid gland is irreversibly destroyed.

How this test is used

  • Hashimoto's Thyroiditis (Autoimmune Hypothyroidism)
  • Graves' Disease (Autoimmune Hyperthyroidism - often concurrent with TSI)
  • Postpartum Thyroiditis
  • Autoimmune Polyglandular Syndrome

Before your appointment

Plan your visit.

Fasting
Follow retailer guidance

How to prepare

  • Fasting Not Required: Circulating IgG autoantibodies (TPO and TgAb) are highly stable macromolecules. Their concentrations do not acutely fluctuate in response to fasting or recent meals. Fasting is 0 hours.
  • Mandatory Biotin Washout (72 Hours): This is the single most critical pre-analytical preparation step. Modern reference laboratories utilize an Electrochemiluminescence Immunoassay (ECLIA) that relies heavily on a streptavidin-biotin binding matrix to quantify both TPO and Tg antibodies. High doses of supplemental Biotin (Vitamin B7)—ubiquitous in hair/skin/nail gummies, B-complexes, and prenatal vitamins—severely interfere with this assay, frequently causing falsely negative or falsely low results. You must completely discontinue all biotin-containing supplements 72 hours prior to the blood draw.
  • Thyroid Medication Continuity: If you are already taking Levothyroxine (Synthroid) or Natural Desiccated Thyroid (Armour/NP), do not stop your medication. The antibodies reflect long-term immune memory, which is not masked by exogenous hormone ingestion on the day of the test.

Important considerations

The 'Healthy Positive' Phenomenon & Assay Limitations: It is clinically established that approximately 10% of the healthy adult population (especially older females) may carry low-titer TPO or Tg antibodies without ever progressing to clinical disease. Antibody presence must always be correlated with a physical ultrasound and a full thyroid hormone panel. Additionally, in patients being monitored for thyroid cancer, high Tg antibodies can mask the detection of Thyroglobulin tumor markers, requiring specialized mass spectrometry (LC-MS/MS) reflex testing.

Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.

See what to expect

Sample reports & resources.

Published examples and supporting files for this test.

No sample files are published for this test yet.

Looking for your own results? Open your reports dashboard

For a closer look

Sources & further reading.

Further reading

Recent Clinical Breakthroughs (2025-2026):

  • Pregnancy Intervention Guidelines: Following a landmark 2025 multinational trial published in The Journal of Clinical Endocrinology & Metabolism, treatment protocols have shifted drastically. For pregnant women who are completely euthyroid (normal TSH/T4) but highly positive for both TPO and Tg antibodies, the administration of low-dose Levothyroxine in the first trimester is now strongly recommended to suppress local glandular inflammation and significantly reduce the rate of spontaneous abortion.
  • Thyroglobulin Antibodies and Differentiated Thyroid Cancer: 2026 clinical oncology guidelines have highlighted a new utility for TgAb tracking. In patients who have undergone thyroidectomy for papillary thyroid cancer, a rising titer of Thyroglobulin antibodies—even if the actual Thyroglobulin tumor marker is undetectable—is now recognized as a highly sensitive, independent surrogate biomarker for cancer recurrence, prompting immediate high-resolution neck ultrasound.
  • Biotin Interference FDA Mandates: In early 2025, the FDA updated its safety communications regarding immunoassay interference. It was documented that thousands of patients were falsely told their Hashimoto's was "in remission" due to falling antibody titers, which were entirely artifactual—caused by the skyrocketing use of mega-dose biotin supplements in the wellness space. This solidified the absolute necessity of the 72-hour clinical washout protocol for antibody testing.

Sources